Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)
Taiwan · Delayed Price · Currency is TWD 77.70
-0.40 (-0.51%)
Mar 26, 2026, 1:30 PM CST
Foresee Pharmaceuticals Revenue
In the year 2025, Foresee Pharmaceuticals had annual revenue of 431.27M TWD with 3.01% growth. Foresee Pharmaceuticals had revenue of 52.21M in the quarter ending December 31, 2025, a decrease of -62.85%.
Revenue
431.27M
Revenue Growth
+3.01%
P/S Ratio
28.38
Revenue / Employee
n/a
Employees
15
Market Cap
12.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 431.27M | 12.59M | 3.01% |
| Dec 31, 2024 | 418.69M | 223.65M | 114.67% |
| Dec 31, 2023 | 195.04M | -106.47M | -35.31% |
| Dec 31, 2022 | 301.51M | 75.48M | 33.39% |
| Dec 31, 2021 | 226.03M | -4.41M | -1.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grape King Bio | 10.25B |
| YungShin Global Holding | 8.37B |
| Standard Chemical & Pharmaceutical | 7.02B |
| TTY Biopharm Company | 6.45B |
| Synmosa Biopharma | 6.11B |
| Formosa Laboratories | 4.85B |
| ScinoPharm Taiwan | 3.16B |
| Handa Pharmaceuticals | 1.62B |